Latest Chronic myelogenous leukemia Stories
Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks.
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues from the UF Shands Cancer Center in Gainesville, Fla., have found that cases of myeloid malignancies are being underreported since a change in registry protocols and laboratory practices starting in 2001.
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib.
According to court documents, on Jan. 18th, 2012 Norvel Dorsey, a Texas man, filed the lawsuit No. B-0191669 in Jefferson County District Court, Texas. Mr.
New research takes aim at stubborn cancer stem cells that are thought to be responsible for treatment resistance and relapse.
About one in five or six cases of adult leukemia in Western populations relates to so-called chronic myeloid leukemia, or CML.
- a meat pie that is usually eaten at Christmas in Quebec